BioVersys AG (SWX:BIOV)
Switzerland · Delayed Price · Currency is CHF 22.60
-0.80 (-3.42%)
At close: Jan 9, 2026
BioVersys AG Market Cap
BioVersys AG has a market cap or net worth of 132.17 million as of January 9, 2026.
Market Cap
132.17M
Enterprise Value
58.34M
Revenue
1.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.60
Market Cap Chart
Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 132.17M, a decrease of -36.44%. That is a compound annual growth rate of -38.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 132.17M | -7.38% |
| Dec 30, 2025 | 142.69M | -31.37% |
| Feb 6, 2025 | 207.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 289.69B |
| Novartis AG | 218.28B |
| Lonza Group AG | 38.77B |
| Galderma Group AG | 38.74B |
| Alcon | 31.71B |
| Sandoz Group AG | 26.07B |
| Straumann Holding AG | 15.95B |
| Sonova Holding AG | 12.60B |